CORNEA ASSOCIATES OF TEXAS
🇺🇸United States
Safety & Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution
Phase 1
Completed
- Conditions
- Pellucid Marginal Corneal DegenerationCorneal DegenerationKeratoconusCorneal Ectasia
- Interventions
- Combination Product: PXL-330 Platinum device for crosslinking with Peschke riboflavin solution
- First Posted Date
- 2020-12-14
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- Cornea Associates of Texas
- Target Recruit Count
- 249
- Registration Number
- NCT04667572
- Locations
- 🇺🇸
Cornea Associates of Texas, Dallas, Texas, United States
Safety and Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution
Phase 1
Completed
- Conditions
- Corneal EctasiaCorneal DegenerationPellucid Marginal Corneal DegenerationKeratoconus
- Interventions
- Combination Product: PXL-330 Platinum device for crosslinking with Peschke riboflavin solution
- First Posted Date
- 2019-11-26
- Last Posted Date
- 2022-10-19
- Lead Sponsor
- Cornea Associates of Texas
- Target Recruit Count
- 200
- Registration Number
- NCT04177082
- Locations
- 🇺🇸
Cornea Associates of Texas, Dallas, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath